Cargando…

1528. A Real-World Perspective on Treatment of CRE UTIs With Oral Agents

BACKGROUND: Treatment approaches for carbapenem-resistant Enterobacteriaceae (CRE) urinary tract infections (UTIs) are typically limited to salvage agents with considerable toxicity or novel β-lactam/β-lactamse inhibitor combinations that are best used judiciously. Doxycycline (DOX) and fosfomycin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babiker, Ahmed, Clarke, Lloyd, Shields, Ryan K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253722/ http://dx.doi.org/10.1093/ofid/ofy210.1357

Ejemplares similares

2420. A Real-World Perspective on the Efficacy of Fosfomycin for Treatment of Multidrug-Resistant Pathogens Causing Urinary Tract Infections
por: Babiker, Ahmed, et al.
Publicado: (2018)

2247. Real-world Experience with Meropenem–Vaborbactam (M/V) for Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Shields, Ryan K, et al.
Publicado: (2019)

1528. Rates of Peripheral Blood Culture Contamination in an Urban Children’s Hospital
por: Tam, Derek, et al.
Publicado: (2019)

Understanding patient and clinician perspectives of antibiotic use for the treatment of UTIs
por: Hannum, Susan, et al.
Publicado: (2020)

Practical Story: Real People, Real Urine, Unreal UTI
por: Offiong, Charlene, et al.
Publicado: (2019)

LB1528C. Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
por: Naggie, Susanna
Publicado: (2022)

P16 UTI Friday: a review of antibiotic prophylaxis in the management of recurrent UTI in primary care
por: Tucker, Avril
Publicado: (2023)

1528 Ralteragir Containing regimen, for Post Exposure Prophylaxis (PEP), well tolerated in Health Care Workers (HCW)
por: Bourgi, Kassem, et al.
Publicado: (2014)

1433. Impact of 2019 US Food and Drug Administration (FDA) Guidance on Developing Drugs for Urinary Tract Infection (UTI) on the Perceived Efficacy of Antibiotics for the Treatment of Uncomplicated UTI (uUTI)
por: Henriksen, Anne Santerre, et al.
Publicado: (2021)

1528. Prevalence of Human Papillomavirus Infection and Cervical Intra-Epithelial Lesions in A Subset of Arab American Women in Southeast Michigan
por: Shallal, Anita, et al.
Publicado: (2020)

LB1528. Results from ACTIV-6: A Decentralized, Double-Blinded, Randomized, Placebo-Controlled Platform Trial of Repurposed Drugs for the Treatment of Mild-to-Moderate COVID-19
por: McCarthy, Matthew W
Publicado: (2022)

1528. Retrospective cohort study of factors associated with non-initiation of antiretroviral therapy among adults newly diagnosed with HIV in Andijan, Uzbekistan, 2018-2021
por: Usmanov, Shokhruh, et al.
Publicado: (2023)

1627. Tedizolid is Well-tolerated Among Patients Receiving Prolonged Treatment Courses, Including Those Who are Intolerant of Alternative Agents
por: Smith, Brandon, et al.
Publicado: (2020)

Spanish explorers in the Southern United States, 1528- 1543 : the Narrative of Alvar Nuñez Cabeza de Vaca /
Publicado: (1925)

2065. Whole Genome Sequencing for Antimicrobial Resistance Prediction in MRSA and VRE: A Real-world Application
por: Babiker, Ahmed, et al.
Publicado: (2018)

2421. Tedizolid Is Well-Tolerated Among Patients Receiving Prolonged Treatment Courses
por: Marini, Rachel V, et al.
Publicado: (2018)

710. In Vitro Activity and Performance of Available Susceptibility Testing Methods for Eravacycline Against Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Jones, Chelsea E, et al.
Publicado: (2019)

P07 Impact of menopausal status and recurrent urinary tract infections (UTIs) on symptoms, severity, and daily life: findings from an online survey of women reporting a recent UTI
por: Sanyaolu, Leigh, et al.
Publicado: (2023)

104. Accuracy of ChatGPT for UTI Diagnosis and Management Questions
por: Gupta, Kalpana, et al.
Publicado: (2023)

794. Healthcare-Associated Urinary Tract Infection (HA-UTI): A Risk Factor for Clostridioides difficile Infection (CDI)? Results of a Real-World Data Analysis
por: Kelly, Timothy, et al.
Publicado: (2020)

La Catedral de San Cristóbal de Las Casas, Chiapas, 1528-1978 /
por: Flores Ruiz, Eduardo, 1890-1977
Publicado: (1978)

2222. 3-Day Ceftriaxone vs. Longer Durations of Therapy For Inpatient Treatment of Uncomplicated UTI 
por: Elajouz, Balsam, et al.
Publicado: (2022)

485. Clinical and Molecular Epidemiology of Carbapenem Non-susceptible Citrobacter sp.
por: Babiker, Ahmed, et al.
Publicado: (2019)

2223. A comparative analysis of the detection of UTI pathogens via culture method and the Open Array-nanofluidic real time PCR method
por: Upadhyay, Pallavi, et al.
Publicado: (2022)

2410. Clinical outcomes and antimicrobial management strategies of Pseudomonas endocarditis
por: Shah, Sunish, et al.
Publicado: (2023)

2667. Does Ceftazidime–Avibactam (CAZ-AVI) Improve Short- and Long-Term Outcomes Among Solid-Organ Transplant (SOT) Recipients with Carbapenem-Resistant Enterobacteriaceae (CRE) Infections?
por: Sun, Jonathan, et al.
Publicado: (2019)

2775. Clinical Outcomes and Treatment-Emergent Resistance of Piperacillin-tazobactam, Cefepime, Carbapenems and Fluoroquinolones for the Treatment of Bloodstream Infections due to AmpC β-Lactamase-Producing Enterobacterales
por: Jawanda, Jasanjeet, et al.
Publicado: (2023)

2209. Reducing Inappropriate Antibiotic Prescribing for the Treatment of Urinary Tract Infections (UTI) in Urgent Care Clinics
por: Vu, Christine A, et al.
Publicado: (2023)

1420. Descriptive Epidemiology of UTI Hospitalizations in the US, 2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

1114. Exploring bactericidal activity and emergence of resistance for carbapenem-resistant Enterobacterales (CRE) with and without Klebsiella pneumoniae carbapenemase (KPC) treated with optimized meropenem (MEM) and meropenem-vaborbactam (MEV) exposures
por: Squires, Kevin M, et al.
Publicado: (2023)

PO-1528 Mood disorder in cancer patients undergoing radiotherapy during the COVID-19 outbreak
por: Nardone, V., et al.
Publicado: (2021)

2128. In Vitro Activity of Ceftibuten-Avibactam and Comparator Agents Against Resistant Enterobacterales from UTIs Collected Globally as Part of the ATLAS Surveillance Program, 2022
por: Hackel, Meredith, et al.
Publicado: (2023)

499. Carbapenem-resistant Enterobacteriaceae (CRE)-associated Infections and Prolonged Colonization among Hospitalized Patients Colonized by CRE
por: Khawcharoenporn, Thana, et al.
Publicado: (2019)

A Systematized Review of UTI Management Protocol for Long-Term Care Residents
por: Arora, Akanksha, et al.
Publicado: (2020)

42. INSPIRE-ASP UTI Trial: A 59 Hospital Cluster Randomized Evaluation of INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Urinary Tract Infection (UTI)
por: Gohil, Shruti K, et al.
Publicado: (2021)

La historia de Texas en la Biblioteca Nacional de México, 1528-1848 : bibliografía comentada /
por: Curiel, Guadalupe
Publicado: (1994)

Effects of Oxygen Transference on Protease Production by Rhodotorula mucilaginosa CBMAI 1528 in a Stirred Tank Bioreactor
por: Machado, Suellen, et al.
Publicado: (2022)

1521. Heterogeneity of Recent Phase 3 cUTI Clinical Trials with New Antibiotics
por: Bass, Almasa, et al.
Publicado: (2018)

THE ASSOCIATION BETWEEN NURSING HOME IT MATURITY AND UTIS AMONG LONG-TERM NH RESIDENTS
por: Alexander, Gregory
Publicado: (2022)

126. Robust and Persistent Vaginal Colonization with LACTIN-V Vaginal Lactobacillus crispatus Probiotic in a Double-Blind, Placebo-Controlled (DBPC) Phase 2b Trial to Prevent Recurrent UTI (rUTI)
por: Stapleton, Ann, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_evlcdf315foofbeo5g27tnqur6